找化学品上960化工网!
960化工网

环孢素 A | 59865-13-3

环孢素 A
Cyclosporin A
59865-13-3
C62H111N11O12
1202.6113
如需查看该化合物的详细结构式,mol文件,smile,InChi 请点击:环孢素 A结构式
环孢素 AMSDS
5284373
环孢素 A价格
简介
Cyclosporin A (Cyclosporine A) 是一种免疫抑制剂,能与亲环素结合,抑制 calcineurin 活性的IC50 值为 7 nM。Cyclosporin A 也抑制 CD11a/CD18 粘附分子。
名称和标识符
MDL MFCD00274558
InChIKey PMATZTZNYRCHOR-CGLBZJNRSA-N
Inchi 1S/C62H111N11O12/c1-25-27-28-40(15)52(75)51-56(79)65-43(26-2)58(81)67(18)33-48(74)68(19)44(29-34(3)4)55(78)66-49(38(11)12)61(84)69(20)45(30-35(5)6)54(77)63-41(16)53(76)64-42(17)57(80)70(21)46(31-36(7)8)59(82)71(22)47(32-37(9)10)60(83)72(23)50(39(13)14)62(85)73(51)24/h25,27,34-47,49-52,75H,26,28-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/b27-25+/t40-,41+,42-,43+,44+,45+,46+,47+,49+,50+,51+,52-/m1/s1
SMILES O([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])/C(/[H])=C(\[H])/C([H])([H])[H])[C@@]1([H])C(N([H])[C@]([H])(C(N(C([H])([H])[H])C([H])([H])C(N(C([H])([H])[H])[C@]([H])(C(N([H])[C@]([H])(C(N(C([H])([H])[H])[C@]([H])(C(N([H])[C@@]([H])(C([H])([H])[H])C(N([H])[C@]([H])(C([H])([H])[H])C(N(C([H])([H])[H])[C@@]([H])(C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C(N(C([H])([H])[H])[C@]([H])(C(N(C([H])([H])[H])[C@]([H])(C(N1C([H])([H])[H])=O)C([H])(C([H])([H])[H])C([H])([H])[H])=O)C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])=O)=O)=O)=O)C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])=O)C([H])(C([H])([H])[H])C([H])([H])[H])=O)C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])=O)=O)C([H])([H])C([H])([H])[H])=O
BRN 3647785
别名信息
- 中文别名 -
  • 环孢素 A
  • 环孢素
  • 环胞霉素 A
  • 环胞菌素
  • 抗生素S
  • 环胞霉素
  • 环孢菌素A
  • 环孢菌素
  • 环孢菌素 USP标准品
  • 环孢菌素(环孢素)
  • 环孢菌素,环孢霉素A
  • 环孢菌素A,Cyclosporin A,植物提取物,标准品,对照品
  • 环孢菌素A标准品
  • 环孢菌素标准品(JP)
  • 环孢霉素A
  • 环孢霉素A 标准品
  • 环孢霉素A,BR
  • 环孢素 EP标准品
  • 环孢素(环孢素A)
  • 环孢素-A
  • 环孢素A标准品
  • 环孢素系统适用性 EP标准品
  • 环胞霉素A 标准品
  • [(E)(2S,3R,4R)-3-羟基-4-甲基-2-(甲氨基)-6辛烯酰]-L-2氨基丁酰-N-甲基甘氨酰-N-甲基-L-亮氨酰-L-缬氨酰-N-甲基-L-亮氨酰-L-丙氨酰-D-丙氨酰-N-甲基-L-亮氨酰-N-甲基-L-亮氨酰-N-甲基-L-缬氨酰
  • 环孢多肽A
  • 环孢菌素分离度用混合物
  • 环孢灵
  • 环孢素分离度用混合物
  • 环蒽孢A
  • 赛斯平
  • 山地明
  • 出地明
  • 抗生素S 7481F1
  • 环孢菌素 环孢菌素 环孢素 环胞菌素
  • 环孢素环孢菌素杂质
  • 环孢菌素, 环孢素, 抗生素S 7481F1,环孢多肽A,环孢灵,出地明
  • 环胞霉素A.环孢素A
  • 环胞霉素A, 98%+
  • 环孢菌素 A 溶液
  • 环孢素A
- 英文别名 -
  • Cyclosporin A
  • Cyclosporin A (Cyclosporine ,Antibiotic S 7481F1,Ciclosporin A, Ramihyphin A,CsA)
  • Cyclosporin A solution
  • CYCLOSPORIN A, TOLYPOCLADIUM INFLATUM
  • Cyclosporine
  • Cyclosporine A
  • Atopica
  • ciclosporin
  • ciclosporin A
  • Cipol N
  • Cyclosporin A from Tolypocladium inflatum
  • Cyclosporine Resolution Mixture
  • Neoplanta
  • Neoral
  • ol27-400
  • Optimmune
  • Restasis
  • s7481f1
  • sandimmun
  • sandimmun neoral
  • Sandimmun optoral
  • Cyclosporin
  • Antibiotic S 7481F1
  • Ciclosporine
  • Ciclosporinum
  • Ciclosporina
  • Sandimmune
  • Equoral
  • Gengraf
  • Consupren
  • Ramihyphin A
  • SangCyA
  • 83HN0GTJ6D
  • MLS001333756
  • CSA
  • S-Neoral
  • Sang 35
  • DSSTox_CID_365
  • Ciclosporinum [INN-Latin]
  • Ciclosporine [INN-French]
  • Ciclosporina [INN-Spanish]
  • DSSTox_RID_75541
  • Ciclosporin (Ciclo
  • sandimmune
  • Cyclospori
  • 1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane, cyclic peptide deriv.
  • 30-Ethyl-33-(1-hydroxy-2-methyl-hex-4-enyl)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-dipropan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
  • Ciclosporin
  • CsA
  • Tox21_110667
  • VEVYE
  • (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,2
  • Pulminiq
  • 1c5f
  • CYCLOSPORINE [VANDF]
  • Cyclokat
  • OLO-400
  • Cyclo(((E)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl)-L-2-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl)
  • Consupren S
  • Cyclosporine
  • Ciclosporin
  • CYCLOSPORIN A [MI]
  • Cyclosporin A, >=98.5% (TLC)
  • MLS000028376
  • Cyclosporine [USAN]
  • BMT-ABA-SAR-MLE-VAL-MLE-ALA-DAL-MLE-MLE-MVA
  • Tox21_110667_1
  • BDBM50022815
  • C62H111N11O12
  • Sang-35
  • NSC290193
  • PMATZTZNYRCHOR-CGLBZJNRSA-N
  • ST-603
  • SBI-0050230.P003
  • EX-A4110
  • MFCD00274558
  • DTXCID00365
  • NSC 290193
  • NCGC00164258-03
  • M01532
  • Sandimmun Neoral
  • (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
  • Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl)-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl)
  • NCGC00164258-01
  • Papilock
  • 30-Ethyl-33-(1-hydroxy-2-methyl-hex-4-enyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
  • Papilock Mini
  • CsA & IFN.alpha.
  • NCGC00164258-02
  • 4jjm
  • Q-200913
  • CB-01-09 MMX
  • Arpimune ME
  • BRD-K03222093-001-01-8
  • S 7481F1
  • 30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
  • Vekacia
  • (R-(R*,R*-(E)))-Cyclic(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alpha-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl)
  • Cyclosporine microemulsion
  • Abrammune
  • NCGC00016890-01
  • (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-((1R,2R,E)-1-hydroxy-2-methylhex-4-en-1-yl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
  • ATH-002
  • 2wfj
  • Sang-2000
  • SCHEMBL4442
  • OL-27400
  • CICLOSPORIN [WHO-IP]
  • 104250-72-8
  • Mitogard
  • Prestwick_731
  • NCGC00093704-12
  • AKOS015969287
  • Sandimmun
  • CAS-59865-13-3
  • Cyclosporin A & IFN.alpha.
  • BMT-ABA-SAR-MLE-VAL-MLE-ALA-ALA-MLE-MLE-MVA
  • Cyclosporin A, from Tolypocladium inflatum, >=95% (HPLC), solid
  • Tox21_301849
  • BP-28432
  • Cicloral (antibiotic)
  • Prestwick2_000435
  • MLS002207033
  • Ciclosporin A
  • (R-[R*,R*-(E)])-Cyclic(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alpha-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl)
  • DB00091
  • OL-27-400
  • DTXSID0020365
  • HMS2096G12
  • HMS2089A09
  • CYCLOSPORINE [USP IMPURITY]
  • CYCLOSPORINE [USP-RS]
  • (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methyl-hex-4-enyl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
  • Imusporin
  • Sandimmune Neoral
  • 30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
  • Sigmasporin Microoral
  • Ikervis
  • CCRIS 1590
  • SR-01000780563-3
  • SDZ-OXL-400
  • 2z6w
  • CICLOSPORIN [WHO-DD]
  • BRD-K13533483-001-03-0
  • CHEBI:92233
  • Debio088
  • CHEMBL160
  • Zyclorin
  • NeuroSTAT
  • BC164336
  • CICLOSPORIN [MART.]
  • Ciclosporina Germed
  • SMR000058578
  • CICLOSPORIN [EP MONOGRAPH]
  • CicloMulsion
  • CEQUA
  • UNII-83HN0GTJ6D
  • VERKAZIA
  • BPBio1_000496
  • HMS2230M14
  • Ciclosporin, European Pharmacopoeia (EP) Reference Standard
  • Cyclosporine [USAN:USP]
  • Cyclosporin A, VETRANAL(TM), analytical standard
  • Cipol-N
  • Cyclosporin A, from Tolypocladium inflatum, BioReagent, for molecular biology, >=95%
  • Ciclosporin
  • Ciclosporin for system suitability, European Pharmacopoeia (EP) Reference Standard
  • HY-B0579
  • (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
  • HSDB 6881
  • CHEBI:4031
  • Prestwick3_000435
  • KS-1257
  • Zinograf ME
  • Ciclosporin [INN]
  • CYCLOSPORINE [GREEN BOOK]
  • SR-01000780563
  • CCG-208184
  • (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methyl-pent-3-enyl]-3,6,9,18,24-pentaisobutyl-21-isopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32
  • cyclosporin A
  • MLS002153454
  • DE-076
  • CYA
  • (R-(R*,R*-(E)))-CYCLIC(L-ALANYL-D-ALANYL-N-METHYL-L-LEUCYL-N-METHYL-L-LEUCYL-N-METHYL-L-VALYL-3-HYDROXY-N,4-DIMETHYL-L-2-AMINO-6-OCTENOYL-L-.ALPHA.-AMINOBUTYRYL-N-METHYLGLYCYL-N-METHYL-L-LEUCYL-L-VALYL-N-METHYL-L-LEUCYL)
  • OL 27-400
  • BSPBio_000450
  • SDCCGSBI-0050230.P004
  • Seciera
  • NCGC00255232-01
  • Sigmasporin
  • HMS1569G12
  • CYCLOSPORINE [IARC]
  • C2408
  • (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecone
  • Modusik-A
  • Cyclosporine manufacturer
  • GTPL1024
  • Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl)
  • Cyclo[[(E)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl]-L-2-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl]
  • CYCLOSPORINE [USP MONOGRAPH]
  • 30-Ethyl-33-((E)-1-hydroxy-2-methyl-hex-4-enyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,28-octamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
  • 1,11-cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(E)-(2S,3R,4R)-2-amino-3-hydroxy-N,4-dimethyloct-6-enoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucine]
  • HMS3713G12
  • CICLOSPORINUM [WHO-IP LATIN]
  • cyclosporine
  • DRG-0275
  • Q367700
  • Nova-22007
  • SCHEMBL3491
  • 59865-13-3
  • ANTIBIOTIC S-7481F1
  • CYCLOSPORINE [ORANGE BOOK]
  • A832514
  • SDZ-OXL 400
  • NSC-290193
  • 1cyn
  • CICLOSPORIN [JAN]
  • CYCLOSPORINE [HSDB]
  • Ciclosporin DT
  • Cyclosporine, United States Pharmacopeia (USP) Reference Standard
  • Cyclosporine, Pharmaceutical Secondary Standard
  • Certified Reference Material
  • AS-13319
  • KBio1_000871
  • FT-0603156
  • Spectrum4_001279
  • KBioSS_000780
  • 5-(N-Methyl-D-valine)-cyclosporin A
  • KBioGR_001898
  • (3R,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
  • KBio2_005916
  • Spectrum3_001593
  • SY012000
  • SPBio_001467
  • KBio3_002686
  • AKOS024456385
  • HMS3654L18
  • NINDS_000871
  • Spectrum2_001484
  • Spectrum_000300
  • CHEBI:201431
  • HMS3267I20
  • HMS3372A06
  • DivK1c_000871
  • FT-0603155
  • FT-0701261
  • HB0220
  • KBio2_000780
  • NCGC00093704-11
  • NS00096465
  • KBio2_003348
  • HMS3651O16
  • AKOS015994720
  • AB00052450_02
  • IDI1_000871
  • NCGC00093704-01
  • A840608
  • US9090657, Cyclosporine A, 1
  • NSC_2909
  • C05086
  • SCHEMBL20475023
  • HMS1989P18
  • NCGC00093704-10
  • CHEBI:91802
  • HMS1791P18
  • Lopac0_000242
  • Pharmakon1600-01502202
  • PMATZTZNYRCHOR-IMVLJIQESA-N
  • NCGC00093704-06
  • NCGC00093704-09
  • Restasis (TN)
  • HMS3412G21
  • Tox21_500242
  • SR-01000075490-1
  • NCGC00093704-08
  • BRD-A64290322-001-01-6
  • BSPBio_003186
  • HMS1921L20
  • 3C152
  • Spectrum5_001628
  • SCHEMBL3490
  • NSC-758194
  • CAS_2909
  • HMS2092F06
  • LMPK14000003
  • EU-0100242
  • NCGC00093704-43
  • NCGC00093704-03
  • BDBM86672
  • Neoral (TN)
  • D00184
  • NSC758194
  • BRD-A69815203-001-04-3
  • NCGC00093704-17
  • SPECTRUM1502202
  • LP00242
  • NCGC00093704-07
  • AKOS015895103
  • SR-01000075490-6
  • CCG-39214
  • HMS3676G21
  • Sandimmune (TN)
  • Cyclosporine (USP)
  • NCGC00260927-01
  • NCGC00093704-35
  • Ciclosporin (JP17)
  • HMS502L13
  • BSPBio_001596
  • LS-15525
  • NP444
  • NS00003734
  • 30-ethyl-33-[(E)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
  • Helv Chim Acta 60: 1568 (1977)
  • Gengraf (TN)
  • SR-01000075490
  • BDBM172718
  • HMS3260B06
  • SR-01000075490-7
  • C 3662
  • SR-01000075490-3
  • NCGC00093704-04
  • CHEMBL386389
  • NCGC00093704-02
  • BRD-A69815203-001-05-0
  • NCGC00093704-05
物化性质
实验特性
LogP 4.14950
PSA 278.80000
Merck 2752
折射率 1.6500 (estimate)
水溶性 Soluble in dimethyl sulfoxide and ethanol. Insoluble in water.
沸点 1293.8℃ at 760 mmHg
熔点 151°C(lit.)
闪点 87℃
溶解度 ethanol: 30 mg/mL
颜色与性状 白色针状结晶,从-15℃的丙酮中得到。
比旋光度 -185.0° - -196.0° (c=0.5, MeOH)
密度 0.9913 (rough estimate)
计算特性
精确分子量 1201.84000
氢键供体数量 5
氢键受体数量 12
可旋转化学键数量 15
同位素质量 1201.841
重原子数量 85
复杂度 2330
同位素原子数量 0
确定原子立构中心数量 12
不确定原子立构中心数量 0
确定化学键立构中心数量 1
不确定化学键立构中心数量 0
共价键单元数量 1
疏水参数计算参考值(XlogP) 7.5
互变异构体数量 16
表面电荷 0
拓扑分子极性表面积 279
国际标准相关数据
EINECS MFCD00274558
海关数据
海关编码 2941909000
海关数据

中国海关编码:

2941909000
生产方法和用途
方法
以多孢木霉菌(Tolypocladium inflatum Cams)为生产菌株。75L罐内装50L种子培养基,接种5×109个孢子,Ph=5.4—4.3,培养72h,得到一级种子液。750L发酵罐内装500L发酵培养基,种入上述一级种子液,培养6天,得二级种子液。4500L发酵罐内装3000L发酵培养基,发酵12天,得到环孢素发酵毒。往发酵液中加人等体积的乙酸乙酯提取,分出有机层,减压蒸发,得粗品。融化处理,可得环孢素和环孢菌素C组分,其中环孢素的产量约为150~200mg/L环孢菌素C约为50~100mg/L。
用途
新型免疫抑制剂。为由十一个氨基酸组成的环状多肽物质。它抑制体液和细胞传递的免疫功能,而不抑制骨髓,不减少白细胞数。能阻止对移植组织或器官的排斥作用。临床用于肾移植,肝、肺移植及心脏移植,另外,对自身免疫疾病,以及血吸虫病、疟疾、糖尿病、艾滋病等有一定疗效,还有抗炎症性能。
治疗白血病、癌、肾移植、结核病等。
抑制T细胞受体信号传导路径 。
专业数据库参考
PubChemId 5284373
参考资料
Reaxys RN 3647785
Beilstein 3647785
环孢素 A推荐生产厂家
环孢素 A相关资讯
960化工网为您提供环孢素 A专业化合物百科信息,包括中文名,英文名,分子式,分子量,以及该化合物的CasNo.:59865-13-3,和相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等
平台客服 平台客服

平台在线客服